Canadian regulators approve Covidien's imaging agent

07/6/2009 | American City Business Journals

Health Canada has approved Covidien's abbreviated new drug submission for its kit used in preparing Technetium Tc 99m Sestamibi Injection, a generic version of Dupont's Cardiolite. With the approval, Covidien said it could have the myocardial perfusion imaging agent on the Canadian market this summer.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Associate Manager, Regulatory Affairs
Mahwah, NJ
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC